What's Happening?
Frankie Montas, a pitcher for the New York Mets, has been placed on the 15-day injured list due to a significant UCL injury in his right elbow. This development was confirmed by Mets manager Carlos Mendoza, who stated that Montas will not pitch again in the 2025 season. Montas, who signed a $34 million contract with the Mets, has struggled throughout the season, managing only 38 2/3 innings with a 6.28 ERA. His performance issues began with a lat strain during Spring Training, which delayed his season debut until June. Despite a promising start, Montas's subsequent performances led to his reassignment to the bullpen. The Mets have not yet disclosed the full extent of the injury or the potential timeline for Montas's recovery.
AD
Why It's Important?
The injury to Frankie Montas is a significant setback for the New York Mets, impacting their pitching depth and financial investment. Montas was expected to be a key player in the Mets' rotation, and his absence leaves a gap that the team must fill. The injury also raises concerns about the potential need for Tommy John surgery, which could sideline Montas for an extended period, possibly affecting the 2026 season as well. This situation highlights the risks associated with high-value contracts in professional sports, where player health can dramatically alter team dynamics and financial planning.
What's Next?
The Mets will need to adjust their pitching strategy in Montas's absence. Huascar Brazoban has been called up from Triple-A to fill Montas's roster spot, taking on the role of long reliever. The team will rely on its remaining rotation, including Sean Manaea, Kodai Senga, and others, to maintain competitive performance. The Mets' management will likely monitor Montas's recovery closely and consider potential trades or acquisitions to bolster their pitching staff if necessary. Fans and analysts will be watching for updates on Montas's condition and any decisions regarding surgical intervention.
